0.71% | % of shares held by all insiders |
80.51% | % of shares held by institutions |
81.09% | % of float held by institutions |
106 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
NEA Management Company, LLC | 7,692,298 | 30 Mar 2024 | 15.23% | 27,999,965 |
FMR, LLC | 5,340,802 | 30 Mar 2024 | 10.57% | 19,440,519 |
Price (T.Rowe) Associates Inc | 5,096,787 | 30 Mar 2024 | 10.09% | 18,552,305 |
Baker Brothers Advisors, LLC | 4,916,095 | 30 Mar 2024 | 9.73% | 17,894,586 |
Avoro Capital Advisors LLC | 4,535,000 | 30 Mar 2024 | 8.98% | 16,507,400 |
Blackrock Inc. | 2,307,009 | 30 Mar 2024 | 4.57% | 8,397,513 |
Vanguard Group Inc | 1,635,829 | 30 Mar 2024 | 3.24% | 5,954,417 |
Aisling Capital Management LP | 1,472,331 | 30 Mar 2024 | 2.91% | 5,359,284 |
Alphabet Inc. | 1,464,015 | 30 Mar 2024 | 2.90% | 5,329,014 |
Citadel Advisors Llc | 980,239 | 30 Mar 2024 | 1.94% | 3,568,070 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Price (T.Rowe) New Horizons Fund | 2,941,087 | 30 Mar 2024 | 5.82% | 10,705,556 |
Fidelity Select Portfolios - Biotechnology | 872,705 | 29 Apr 2024 | 1.73% | 3,176,646 |
Vanguard Total Stock Market Index Fund | 845,794 | 30 Mar 2024 | 1.67% | 3,078,690 |
Price (T.Rowe) Health Sciences Fund | 819,434 | 30 Mar 2024 | 1.62% | 2,982,739 |
Fidelity Select Portfolios - Pharmaceuticals | 796,400 | 30 May 2024 | 1.58% | 2,898,896 |
iShares Russell 2000 ETF | 709,514 | 30 May 2024 | 1.40% | 2,582,631 |
Fidelity Advisor Biotechnology Fund | 632,258 | 29 Apr 2024 | 1.25% | 2,301,419 |
Fidelity Small Cap Growth Fund | 622,600 | 29 Apr 2024 | 1.23% | 2,266,264 |
Fidelity Growth Company Fund | 595,209 | 29 Apr 2024 | 1.18% | 2,166,560 |
Price (T.Rowe) New Horizons Trust | 503,604 | 30 Mar 2024 | 1.00% | 1,833,118 |